课题基金 / 基金详情

Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels

Compound 49b Prevents Retinal Endothelial Cell Death Through IGFBP-3 Levels
化合物 49b 通过 IGFBP-3 水平预防视网膜内皮细胞死亡
批准号:
8730663
负责人:
Jena J Steinle
金额:
$10.39万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2014-12-31

项目摘要

项目成果

Jena J Steinle的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Diabetic retinopathy remains the fifth leading cause of preventable blindness worldwide. Interventions to prevent progression of diabetic retinopathy are limited to improved glycemic control (a challenging goal for all diabetic patients) and to lase photocoagulation (available only for advanced stages of retinopathy). We and others have reported that adrenergic signaling is lost in the diabetic retina, suggesting that development of novel agents to restore autonomic homeostasis is necessary. Unfortunately, currently available adrenergic agents are associated with adverse systemic or non-specific effects. These problems inspired our group to synthesize compound 49b, a novel and selective ¿-adrenergic receptor agonist, as a potential paradigm shift in the prevention of diabetic retinopathy. Our preliminary data suggest that compound 49b prevents the formation of degenerate capillaries, which involves degenerate capillary formation, which are the hallmark pathology noted in the diabetic retinal vasculature. In addition to preventing degenerate capillaries in vivo, compound 49b prevents the cleavage of caspase 3, a well- established marker of apoptosis, in retinal endothelial cells (REC) in vitro, suggesting that Compound 49b can decrease apoptosis. In the oxygen-induced model of retinopathy, others have associated increased levels of insulin-like growth factor binding protein-3 (IGFBP-3) with protection from REC apoptosis. Furthermore, using the streptozotocin-induced diabetic rat model, we observed that chronic insulin deficiency reduced IGFBP-3 protein levels in whole retinal lysates, but topical application of compound 49b to the eye restored retinal IGFBP-3 to its control level in these insulin- deficient rats. Thus, we hypothesize that compound 49b prevents the critical vascular damage underlying diabetic retinopathy in part by restoring IGFBP-3 levels in retinal endothelial cells. This project focuses on a deeper understanding of the mechanisms underlying this protective action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PKA and Epac1 inhibit TLR4 to protect the diabetic retina
  • 批准号:
    10554345
  • 项目类别:
  • 资助金额:
    $35.13万
  • 财政年份:
    2020
  • 负责人:
    Jena J Steinle
  • 依托单位:
PKA and Epac1 inhibit TLR4 to protect the diabetic retina
  • 批准号:
    10320378
  • 项目类别:
  • 资助金额:
    $34.07万
  • 财政年份:
    2020
  • 负责人:
    Jena J Steinle
  • 依托单位:
Inhibition of HMGB1 as a protective mechanism against diabetic retinopathy
  • 批准号:
    9899993
  • 项目类别:
  • 资助金额:
    $44.74万
  • 财政年份:
    2018
  • 负责人:
    Jena J Steinle
  • 依托单位:
Compound 49b prevents retinal endothelial cell apoptosis in type 2 diabetes
  • 批准号:
    8666524
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Jena J Steinle
  • 依托单位:
海外基金